Article

Bausch & Lomb lens designed for implantation through 1.8-mm incision

The spherical aberration-free lens has been developed specifically for 1.8-mm microincision cataract surgery (MICS), and the company said it will refer to the lens within the United States as the Akreos MICS. Its award-winning design and glistening-free material allow implantation through a 1.8-mm incision, while maintaining the optical quality and stability established with the parent lens design (Akreos AO).

Rochester, NY—Bausch & Lomb Surgical announced the U.S. launch of its microincision lens (Akreos AO, Model MI60L).

The spherical aberration-free lens has been developed specifically for microincision cataract surgery (MICS), and the company said it will refer to the lens within the United States as the Akreos MICS. Its award-winning design and glistening-free material allow implantation through a 1.8-mm incision while maintaining the optical quality and stability established with the parent lens design (Akreos AO).

When the new lens is coupled with a vision enhancement system (Stellaris, Bausch & Lomb), small-incision surgeons now can benefit from the universal advantages provided by the MICS platform, the company said. Among the advantages are increased wound sealability and a reduction in both endothelial cell loss and surgically induced astigmatism, according to a statement issued by the company.

The Centers for Medicare and Medicaid Services granted new technology intraocular lens (NTIOL) designation to the MICS IOL for its spherical aberration-reducing design. The NTIOL designation became effective April 30 and means Medicare reimbursement to ambulatory surgery centers for cataract surgery will increase by $50 when surgery is performed with the MICS IOL, according to the company.

“We have strategically timed the launch of the . . . MICS IOL in order to best support surgeons and their patients by providing our latest technological advancements in aspheric optics with NTIOL designation,” said Mike Judy, vice president of worldwide marketing, Bausch & Lomb Surgical. “By introducing an advanced technology lens with a designation that recognizes the high level of performance this lens provides, we continue the Bausch & Lomb tradition of delivering quality products and innovation that perfect vision and enhance life.”

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
© 2025 MJH Life Sciences

All rights reserved.